Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(50%)

    Phase Distribution

    No phase data available

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 1 finished

    Non-Completion Rate

    100.0%

    1 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Terminated(1)

    Detailed Status

    Recruiting1
    Withdrawn1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    N/A

    Trials by Status

    recruiting150%
    withdrawn150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    recruiting

    The EXPLORE MG Registry for Myasthenia Gravis

    NCT03792659
    withdrawn

    Clinical and Pathologic Studies in Neuroendocrine Tumors

    NCT00657332

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT03792659

    The EXPLORE MG Registry for Myasthenia Gravis

    Recruiting
    NCT00657332

    Clinical and Pathologic Studies in Neuroendocrine Tumors

    Withdrawn

    All 2 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2